ZA200807054B - N-formyl hydroxylamine compounds - Google Patents
N-formyl hydroxylamine compoundsInfo
- Publication number
- ZA200807054B ZA200807054B ZA200807054A ZA200807054A ZA200807054B ZA 200807054 B ZA200807054 B ZA 200807054B ZA 200807054 A ZA200807054 A ZA 200807054A ZA 200807054 A ZA200807054 A ZA 200807054A ZA 200807054 B ZA200807054 B ZA 200807054B
- Authority
- ZA
- South Africa
- Prior art keywords
- hydroxylamine compounds
- formyl hydroxylamine
- formyl
- compounds
- hydroxylamine
- Prior art date
Links
- KDGKTJGPFXIBEB-UHFFFAOYSA-N n-hydroxyformamide Chemical class > KDGKTJGPFXIBEB-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77937706P | 2006-03-03 | 2006-03-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200807054B true ZA200807054B (en) | 2009-10-28 |
Family
ID=38510154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200807054A ZA200807054B (en) | 2006-03-03 | 2008-08-15 | N-formyl hydroxylamine compounds |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20090062537A1 (xx) |
| EP (1) | EP1994027A2 (xx) |
| JP (1) | JP2009529008A (xx) |
| KR (1) | KR20080095895A (xx) |
| CN (1) | CN101395148A (xx) |
| AU (1) | AU2007226715A1 (xx) |
| BR (1) | BRPI0708524A2 (xx) |
| CA (1) | CA2643267A1 (xx) |
| CR (1) | CR10251A (xx) |
| EC (1) | ECSP088712A (xx) |
| GT (1) | GT200800170A (xx) |
| IL (1) | IL193524A0 (xx) |
| MA (1) | MA30285B1 (xx) |
| MX (1) | MX2008011128A (xx) |
| NO (1) | NO20084069L (xx) |
| RU (1) | RU2008139192A (xx) |
| TN (1) | TNSN08344A1 (xx) |
| WO (1) | WO2007106670A2 (xx) |
| ZA (1) | ZA200807054B (xx) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101584694B (zh) * | 2009-06-15 | 2011-01-12 | 华东师范大学 | 含2,5-二氢吡咯的肽脱甲酰基酶抑制剂及合成方法 |
| CN101869563B (zh) * | 2010-07-02 | 2011-11-16 | 华东师范大学 | 含4-亚甲基吡咯烷的肽脱甲酰基酶抑制剂 |
| AR085698A1 (es) * | 2011-03-09 | 2013-10-23 | Glaxosmithkline Llc | Inhibidores de la peptido desformilasa |
| CN103159660B (zh) * | 2011-12-08 | 2016-07-06 | 天津市国际生物医药联合研究院 | (2r)-1-(2-甲基-3-(甲氧基(甲基)氨基)-丙酰基)吡咯烷-2-羧酸及其应用 |
| HK1208875A1 (en) * | 2012-01-12 | 2016-03-18 | 耶鲁大学 | Compounds & methods for the enhanced degradation of targeted proteins & other polypeptides by an e3 ubiquitin ligase |
| WO2013106646A2 (en) * | 2012-01-12 | 2013-07-18 | Yale University | Compounds and methods for the inhibition of vcb e3 ubiquitin ligase |
| BR112014015582A8 (pt) | 2012-02-24 | 2017-07-04 | Hoffmann La Roche | compostos antivirais |
| GB201311888D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| GB201311891D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compound |
| MX393637B (es) * | 2014-02-06 | 2025-03-11 | Heptares Therapeutics Ltd | Compuestos aza biciclicos como agonistas del receptor muscarinico m1. |
| US20180228907A1 (en) | 2014-04-14 | 2018-08-16 | Arvinas, Inc. | Cereblon ligands and bifunctional compounds comprising the same |
| US10071164B2 (en) | 2014-08-11 | 2018-09-11 | Yale University | Estrogen-related receptor alpha based protac compounds and associated methods of use |
| US12312316B2 (en) | 2015-01-20 | 2025-05-27 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of androgen receptor |
| CA2974367A1 (en) | 2015-01-20 | 2016-07-28 | Arvinas, Inc. | Compounds and methods for the targeted degradation of the androgen receptor |
| CN108601764A (zh) | 2015-03-18 | 2018-09-28 | 阿尔维纳斯股份有限公司 | 用于靶蛋白的增强降解的化合物和方法 |
| US20180147202A1 (en) | 2015-06-05 | 2018-05-31 | Arvinas, Inc. | TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE |
| EP3337476A4 (en) | 2015-08-19 | 2019-09-04 | Arvinas, Inc. | Compounds and methods for the targeted degradation of bromodomain-containing proteins |
| WO2017079267A1 (en) | 2015-11-02 | 2017-05-11 | Yale University | Proteolysis targeting chimera compounds and methods of preparing and using same |
| US20180072711A1 (en) | 2016-09-15 | 2018-03-15 | Arvinas, Inc. | Indole derivatives as estrogen receptor degraders |
| CA3038979A1 (en) | 2016-10-11 | 2018-04-19 | Arvinas, Inc. | Compounds and methods for the targeted degradation of androgen receptor |
| EP3535265A4 (en) | 2016-11-01 | 2020-07-08 | Arvinas, Inc. | PROTACS TARGETING ON TAU PROTEIN AND RELATED METHODS FOR USE |
| RS64976B1 (sr) | 2016-12-01 | 2024-01-31 | Arvinas Operations Inc | Derivati tetrahidronaftalena i tetrahidroizohinolina kao degradatori estrogenih receptora |
| JP7679173B2 (ja) | 2016-12-23 | 2025-05-19 | アルビナス・オペレーションズ・インコーポレイテッド | Ｒａｆ（急速進行性線維肉腫）ポリペプチドの標的分解のための化合物および方法 |
| US11173211B2 (en) | 2016-12-23 | 2021-11-16 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of rapidly accelerated Fibrosarcoma polypeptides |
| WO2018118598A1 (en) | 2016-12-23 | 2018-06-28 | Arvinas, Inc. | Compounds and methods for the targeted degradation of fetal liver kinase polypeptides |
| RU2019121527A (ru) | 2016-12-23 | 2021-01-15 | Эрвинэс Оперейшнс, Инк. | Химерные молекулы, нацеливающиеся на протеолиз egfr, и связанные с ними способы применения |
| US11191741B2 (en) | 2016-12-24 | 2021-12-07 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide |
| CN117551089A (zh) | 2017-01-26 | 2024-02-13 | 阿尔维纳斯运营股份有限公司 | 雌激素受体蛋白水解调节剂及相关使用方法 |
| CA3050309A1 (en) | 2017-01-31 | 2018-08-09 | Arvinas Operations, Inc. | Cereblon ligands and bifunctional compounds comprising the same |
| WO2019099926A1 (en) | 2017-11-17 | 2019-05-23 | Arvinas, Inc. | Compounds and methods for the targeted degradation of interleukin-1 receptor-associated kinase 4 polypeptides |
| EP3743066A4 (en) | 2018-01-26 | 2021-09-08 | Yale University | IMIDE-BASED PROTEOLYSIS MODULATORS AND RELATED METHODS OF USE |
| JP7720698B2 (ja) | 2018-04-04 | 2025-08-08 | アルビナス・オペレーションズ・インコーポレイテッド | タンパク質分解の調節因子および関連する使用方法 |
| JP7297053B2 (ja) | 2018-08-20 | 2023-06-23 | アルビナス・オペレーションズ・インコーポレイテッド | 神経変性疾患を治療するためのｅ３ユビキチンリガーゼ結合活性を有するキメラ（ｐｒｏｔａｃ）化合物を標的とし、アルファ－シヌクレインタンパク質を標的とするタンパク質分解 |
| CN114867727B (zh) | 2019-07-17 | 2025-02-21 | 阿尔维纳斯运营股份有限公司 | Tau蛋白靶向化合物及相关使用方法 |
| KR20220054347A (ko) | 2019-08-26 | 2022-05-02 | 아비나스 오퍼레이션스, 인코포레이티드 | 에스트로겐 수용체 분해제로서의 테트라히드로나프탈렌 유도체로 유방암을 치료하는 방법 |
| CA3154386A1 (en) | 2019-10-17 | 2021-04-22 | Michael Berlin | Bifunctional molecules containing an e3 ubiquitine ligase binding moiety linked to a bcl6 targeting moiety |
| CR20220353A (es) | 2019-12-19 | 2022-10-20 | Arvinas Operations Inc | Compuestos y métodos para la degradación dirigida del receptor de andrógenos |
| CN115996918A (zh) | 2020-05-09 | 2023-04-21 | 阿尔维纳斯运营股份有限公司 | 制造双官能团化合物的方法、双官能团化合物的超纯形式以及包括所述双官能团化合物的剂型 |
| US12180193B2 (en) | 2020-08-28 | 2024-12-31 | Arvinas Operations, Inc. | Accelerating fibrosarcoma protein degrading compounds and associated methods of use |
| JP2023541434A (ja) | 2020-09-14 | 2023-10-02 | アルビナス・オペレーションズ・インコーポレイテッド | エストロゲン受容体の標的化分解のための化合物の結晶性形態 |
| AU2022259683A1 (en) | 2021-04-16 | 2023-10-19 | Arvinas Operations, Inc. | Modulators of bcl6 proteolysis and associated methods of use |
| US11957759B1 (en) | 2022-09-07 | 2024-04-16 | Arvinas Operations, Inc. | Rapidly accelerated fibrosarcoma (RAF) degrading compounds and associated methods of use |
| KR20250151412A (ko) | 2023-01-26 | 2025-10-21 | 아비나스 오퍼레이션스, 인코포레이티드 | 세레블론계 kras 분해 단백질 및 이와 관련된 용도 |
| WO2025122895A1 (en) | 2023-12-08 | 2025-06-12 | Arvinas Operations, Inc. | Use of androgen receptor degrader for the treatment of spinal and bulbar muscular atrophy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR036053A1 (es) * | 2001-06-15 | 2004-08-04 | Versicor Inc | Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas |
| EP1599440A2 (en) * | 2003-02-21 | 2005-11-30 | Novartis AG | Chemical process for the preparation of intermediates to obtain n-formyl hydroxylamine compounds |
-
2007
- 2007-03-02 CN CNA2007800077069A patent/CN101395148A/zh active Pending
- 2007-03-02 JP JP2008557514A patent/JP2009529008A/ja active Pending
- 2007-03-02 BR BRPI0708524-9A patent/BRPI0708524A2/pt not_active IP Right Cessation
- 2007-03-02 CA CA002643267A patent/CA2643267A1/en not_active Abandoned
- 2007-03-02 RU RU2008139192/04A patent/RU2008139192A/ru not_active Application Discontinuation
- 2007-03-02 KR KR1020087021464A patent/KR20080095895A/ko not_active Ceased
- 2007-03-02 MX MX2008011128A patent/MX2008011128A/es not_active Application Discontinuation
- 2007-03-02 AU AU2007226715A patent/AU2007226715A1/en not_active Abandoned
- 2007-03-02 WO PCT/US2007/063167 patent/WO2007106670A2/en not_active Ceased
- 2007-03-02 US US12/280,896 patent/US20090062537A1/en not_active Abandoned
- 2007-03-02 EP EP07757788A patent/EP1994027A2/en not_active Withdrawn
-
2008
- 2008-08-15 ZA ZA200807054A patent/ZA200807054B/xx unknown
- 2008-08-18 IL IL193524A patent/IL193524A0/en unknown
- 2008-08-26 CR CR10251A patent/CR10251A/es unknown
- 2008-09-02 EC EC2008008712A patent/ECSP088712A/es unknown
- 2008-09-02 GT GT200800170A patent/GT200800170A/es unknown
- 2008-09-02 TN TNP2008000344A patent/TNSN08344A1/en unknown
- 2008-09-17 MA MA31247A patent/MA30285B1/fr unknown
- 2008-09-24 NO NO20084069A patent/NO20084069L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0708524A2 (pt) | 2011-05-31 |
| IL193524A0 (en) | 2009-08-03 |
| KR20080095895A (ko) | 2008-10-29 |
| WO2007106670A3 (en) | 2008-01-24 |
| MA30285B1 (fr) | 2009-03-02 |
| RU2008139192A (ru) | 2010-04-10 |
| NO20084069L (no) | 2008-12-03 |
| CA2643267A1 (en) | 2007-09-20 |
| JP2009529008A (ja) | 2009-08-13 |
| MX2008011128A (es) | 2008-09-08 |
| TNSN08344A1 (en) | 2009-12-29 |
| WO2007106670A2 (en) | 2007-09-20 |
| AU2007226715A1 (en) | 2007-09-20 |
| CR10251A (es) | 2008-10-27 |
| ECSP088712A (es) | 2008-10-31 |
| GT200800170A (es) | 2008-10-29 |
| EP1994027A2 (en) | 2008-11-26 |
| US20090062537A1 (en) | 2009-03-05 |
| CN101395148A (zh) | 2009-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200807054B (en) | N-formyl hydroxylamine compounds | |
| IL226046A0 (en) | new compounds | |
| GB0602424D0 (en) | Compounds | |
| GB0602046D0 (en) | Compounds | |
| EP1984379A4 (en) | ANTI-ARENAVIRAL COMPOUNDS | |
| EP2017275A4 (en) | BENZISOXAZOLE COMPOUND | |
| EP2082022A4 (en) | COMPOUNDS | |
| GB0619325D0 (en) | New compounds | |
| EP2004174A4 (en) | NAPHTHALENEDIONED COMPOUNDS | |
| GB0608272D0 (en) | Compounds | |
| GB0602042D0 (en) | Compounds | |
| AP2009004767A0 (en) | Cubstituted azolin-2-yl-amino compounds | |
| GB0625826D0 (en) | New compounds | |
| EP1973905A4 (en) | COMPOUNDS | |
| GB0625827D0 (en) | New compounds | |
| HK1122295A (en) | N-formyl hydroxylamine compounds | |
| GB0600427D0 (en) | Compounds | |
| GB0602560D0 (en) | Compounds | |
| HU0600920D0 (en) | New compounds | |
| HU0600918D0 (en) | New compounds | |
| HU0600726D0 (en) | New compounds | |
| HU0600919D0 (en) | New compounds | |
| GB0611836D0 (en) | New compounds | |
| GB0601505D0 (en) | Compounds | |
| GB0600426D0 (en) | Compounds |